Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Dear Visitor: Equitymaster will be under maintenance from 10:00AM to 11.30AM on Sunday, 25 March 2018. During this period, our websites will be accessible though there is a possibility of some intermittent accessibility issues. Please bear with us. We are taking yet another step to make browsing Equitymaster a much faster experience! Thank you.

Engineering stocks surge
Tue, 13 May 01:30 pm

Indian share markets continued to hover at high levels in the post-noon trading session. Barring pharma, all the sectoral indices are trading in the green with engineering, consumer durable and power stocks being the biggest gainers.

BSE-Sensex is up 354 points and NSE-Nifty is trading 97 points up. BSE Mid Cap is trading 1.2% up and BSE Small Cap index is trading up by 1.1%. The rupee is trading at 59.8 to the US dollar.

All the telecom stocks are trading positive led by MTNL and ITI. As per data released by Telecom Regulatory Authority of India (TRAI), the telecom industry saw an addition of over one million subscribers in March to reach a subscriber base of 933 million. Rural India was the growth driver with the mobile services subscriber base increasing by 2.8 m to reach 377.7 m in March. However, subscriber base in urban India declined by 1 m to 555.3 m for the month of March.

Indian Pharma stocks are trading mixed today. While Panacea Biotech and Aurobindo Pharma are trading higher, Dr. Reddy's is trading on a weak note. As per a leading business daily, Lupin is planning to restructure its domestic operations as domestic growth has slowed down due to lower drug prices on account of the new drug pricing policy. The company wants to divest those brands from its portfolio that generate minimal revenues and lack the key therapies. In addition, Lupin plans to add new products to its portfolio which constitutes critical therapies like cancer drug, where the company lacks presence currently. During 4QFY14, the company's Indian formulation business marginally grew by 2% YoY, while exports surged by 26.4% YoY. Over the past few quarters, growth in the company's domestic business has been under pressure. Lupin stock is trading up marginally.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Engineering stocks surge". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Mar 23, 2018 (Close)